177 related articles for article (PubMed ID: 34419745)
1. Generation of iPSC line from a Parkinson patient with PARK7 mutation and CRISPR-edited Gibco human episomal iPSC line to mimic PARK7 mutation.
Mazza MC; Beilina A; Roosen DA; Hauser D; Cookson MR
Stem Cell Res; 2021 Aug; 55():102506. PubMed ID: 34419745
[TBL] [Abstract][Full Text] [Related]
2. Generation of a human iPSC line (CIBi013-A) from a patient with young-onset Parkinson's disease carrying a novel homozygous PARK7 (DJ-1) mutation.
Li L; Si X; Lei M; Yang J; Ruan J; Liu H; Huang F; Jin X; Xie K; Yang H; Lei X; Liu Y
Stem Cell Res; 2023 Feb; 66():102983. PubMed ID: 36469984
[TBL] [Abstract][Full Text] [Related]
3. Generation of an induced pluripotent stem cell line (GIBHi004-A) from a Parkinson's disease patient with mutant DJ-1/PARK7 (p.L10P).
Li Y; Ibañez DP; Fan W; Zhao P; Chen S; Md Abdul M; Jiang Y; Fu L; Luo Z; Liu Z; Yang Y; Guo J; Volpe G; Kanwal S; Wang D; Tang B; Li W
Stem Cell Res; 2020 Jul; 46():101845. PubMed ID: 32534165
[TBL] [Abstract][Full Text] [Related]
4. Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7.
Chen ZT; Zhao ZH; Chen LN; Fan F; Cai GE; Weng HD; Wang YQ; Liao LM; Chen XC; Huang E; Ye QY
Stem Cell Res; 2021 Mar; 51():102175. PubMed ID: 33485186
[TBL] [Abstract][Full Text] [Related]
5. Generation of isogenic control DJ-1-delP GC13 for the genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A-1).
Mencke P; Hanss Z; Jarazo J; Massart F; Rybicki A; Petkovski E; Glaab E; Boussaad I; Bonifati V; Christian Schwamborn J; Mandemakers W; Krüger R
Stem Cell Res; 2022 Jul; 62():102815. PubMed ID: 35617842
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of a genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A).
Mencke P; Boussaad I; Önal G; Kievit AJA; Boon AJW; Mandemakers W; Bonifati V; Krüger R
Stem Cell Res; 2022 Jul; 62():102792. PubMed ID: 35500378
[TBL] [Abstract][Full Text] [Related]
7. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of human induced pluripotent stem cell line from a Parkinson's disease patient harboring VPS13A gene mutation.
Lu X; Wang W; Liu Y; Song N; Li M; Mu X; Zhang N; Chen Q; Jiang L; Kong X; Sun P; Tong J; Zhang Y; Li J; Ma S; Han F
Stem Cell Res; 2022 Apr; 60():102685. PubMed ID: 35093716
[TBL] [Abstract][Full Text] [Related]
9. Generation of integration-free human iPSC line LCPHi001-A from a Parkinson's disease patient carrying the RecNciI mutation in GBA gene.
Lu X; Song N; Wang W; Liu Y; Song H; Xu L; Wang Y; Wei C; Chen J; Yang X; Han F
Stem Cell Res; 2021 Oct; 56():102514. PubMed ID: 34464855
[TBL] [Abstract][Full Text] [Related]
10. Incidence of mutations in the PARK2, PINK1, PARK7 genes in Polish early-onset Parkinson disease patients.
Koziorowski D; Hoffman-Zacharska D; Sławek J; Jamrozik Z; Janik P; Potulska-Chromik A; Roszmann A; Tataj R; Bal J; Friedman A
Neurol Neurochir Pol; 2013; 47(4):319-24. PubMed ID: 23986421
[TBL] [Abstract][Full Text] [Related]
11. Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutations.
Chen M; Maimaitili M; Buchholdt SH; Jensen UB; Febbraro F; Denham M
Stem Cell Res; 2020 Jan; 42():101657. PubMed ID: 31786474
[TBL] [Abstract][Full Text] [Related]
12. Generation of an induced pluripotent stem cell line (EURACi014-A) from a Parkinson's disease patient with an A53T mutation in the SNCA gene by an integration-free reprogramming method.
Gilmozzi V; Gentile G; Riekschnitz DA; Volpato CB; Di Segni M; Silipigni R; Pramstaller PP; Hicks AA; Pichler I; Zanon A
Stem Cell Res; 2022 Apr; 60():102713. PubMed ID: 35189566
[TBL] [Abstract][Full Text] [Related]
13. Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene.
Marote A; Pomeshchik Y; Collin A; Goldwurm S; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Apr; 28():44-47. PubMed ID: 29414418
[TBL] [Abstract][Full Text] [Related]
14. Generation and characterization of induced pluripotent stem cell (iPSC) lines of two asymptomatic individuals carrying a heterozygous exon 7 deletion in Parkin (PRKN) and two non-carriers from the same family.
Castelo Rueda MP; Gilmozzi V; Riekschnitz DA; Di Segni M; Silipigni R; Pramstaller PP; Hicks AA; Pichler I; Zanon A
Stem Cell Res; 2022 Apr; 60():102692. PubMed ID: 35121197
[TBL] [Abstract][Full Text] [Related]
15. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
[TBL] [Abstract][Full Text] [Related]
16. Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene.
Gustavsson N; Marote A; Pomeshchik Y; Russ K; Azevedo C; Chumarina M; Goldwurm S; Collin A; Pinto L; Salgado AJ; Klementieva O; Roybon L; Savchenko E
Stem Cell Res; 2019 Jan; 34():101373. PubMed ID: 30640063
[TBL] [Abstract][Full Text] [Related]
17. Familial early onset Parkinson's disease caused by a homozygous frameshift variant in PARK7: Clinical features and literature update.
Stephenson SE; Djaldetti R; Rafehi H; Wilson GR; Gillies G; Bahlo M; Lockhart PJ
Parkinsonism Relat Disord; 2019 Jul; 64():308-311. PubMed ID: 30928208
[TBL] [Abstract][Full Text] [Related]
18. Generation of an induced pluripotent stem cell line (EURACi005-A) from a Parkinson's disease patient carrying a homozygous exon 3 deletion in the PRKNgene.
Zanon A; Riekschnitz D; von Troyer M; Volpato C; Picard A; Cantaloni C; Di Segni M; Silipigni R; Pramstaller PP; Hicks AA; Pichler I
Stem Cell Res; 2019 Dec; 41():101624. PubMed ID: 31715428
[TBL] [Abstract][Full Text] [Related]
19. Loss of DJ-1 protein stability and cytoprotective function by Parkinson's disease-associated proline-158 deletion.
Rannikko EH; Vesterager LB; Shaik JH; Weber SS; Cornejo Castro EM; Fog K; Jensen PH; Kahle PJ
J Neurochem; 2013 Apr; 125(2):314-27. PubMed ID: 23241025
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel functional deletion variant in the 5'-UTR of the DJ-1 gene.
Keyser RJ; van der Merwe L; Venter M; Kinnear C; Warnich L; Carr J; Bardien S
BMC Med Genet; 2009 Oct; 10():105. PubMed ID: 19825160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
